Sharda Cropchem Ltd

SHARDACROPPesticides & Agrochemicals
1192.30+0.00 (+0.00%)
As on 06 Feb 2026, 10:15 amMarket Closed

Fundamental Score

...

Sharda Cropchem Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

12.62%
Good

Return on Capital Employed

16.50%
Excellent

Operating Profit Margin (5Y)

15.56%
Average

Dividend Yield

1.03%

Valuation Metrics

Excellent

Price to Earnings

17.41x

Market Capitalization

7.87K (Cr)

Industry P/E

29.36x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

75.22%
Excellent

YoY Quarterly Sales Growth

19.59%
Excellent

Sales Growth (5Y)

16.62%
Poor

EPS Growth (5Y)

8.25%
Poor

Profit Growth (5Y)

8.25%

Financial Health

Excellent

Debt to Equity

0.00x
Excellent

Interest Coverage

317.41x
Excellent

Free Cash Flow (5Y)

412.64 (Cr)

Ownership Structure

Good

Promoter Holding

74.82%
Average

FII Holding

5.26%
Average

DII Holding

9.26%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Mid-cap
Balance of growth potential and stability.
74.82%
Promoter Holding
7.87K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of SHARDACROP across key market metrics for learning purposes.

Positive Indicators

11 factors identified

Excellent ROCE Performance (16.50%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Strong Operating Margins (15.56%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Attractive Valuation (P/E: 17.41 vs Industry: 29.36)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Robust Profit Growth (75.22%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (19.59%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (16.62% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Interest Coverage (317.41x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Strong Cash Generation (₹412.64 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (74.82%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

0 factors identified

No significant concerns identified in current analysis.

Financial Statements

Comprehensive financial data for Sharda Cropchem Ltd

About SHARDACROP

Business Overview

Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as well as cotton transmission belts, PVC and polyurethane light duty belting products, and V-belts. In addition, it offers industrial chemicals used in water treatment, food and food ingredients, and other industrial applications; and dyes and dye intermediates, as well as general chemicals. Further, the company supplies and distributes pharmaceuticals and intermediates products, including prothioconazole, azoxystrobin, P-nitrophenol - parathion-methyl, 2,4-dichloroacetophenone - propiconazole, cyclopropanecarboxylic acid - trinexapac-ethyl, and P-fluorobenzaledehyde - cyfluthrin. Sharda Cropchem Limited was founded in 1987 and is based in Mumbai, India.

Company Details

Symbol:SHARDACROP
Industry:Pesticides & Agrochemicals
Sector:Pesticides & Agrochemicals

Key Leadership

Mr. Ramprakash Vilasrai Bubna
Founder, Chairman & MD
Mr. Manish Ramprakash Bubna
Founder & Whole-Time Director
Mr. Ashish Ramprakash Bubna
Founder & Whole-Time Director

Corporate Events

Recent
Ex-Dividend Date
2025-08-07

SHARDACROP Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)12.62%
Return on Capital Employed16.50%
Operating Profit Margin (5Y)15.56%
Debt to Equity Ratio0.00
Interest Coverage Ratio317.41

Growth & Valuation

Sales Growth (5Y)16.62%
Profit Growth (5Y)8.25%
EPS Growth (5Y)8.25%
YoY Quarterly Profit Growth75.22%
YoY Quarterly Sales Growth19.59%

Frequently Asked Questions

What is the current price of Sharda Cropchem Ltd (SHARDACROP)?

As of 06 Feb 2026, 10:15 am IST, Sharda Cropchem Ltd (SHARDACROP) is currently trading at ₹1192.30. The stock has a market capitalization of ₹7.87K (Cr).

Is SHARDACROP share price Overvalued or Undervalued?

SHARDACROP is currently trading at a P/E ratio of 17.41x, compared to the industry average of 29.36x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Sharda Cropchem Ltd share price?

Key factors influencing SHARDACROP's price include its quarterly earnings growth (Sales Growth: 19.59%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Sharda Cropchem Ltd a good stock for long-term investment?

Sharda Cropchem Ltd shows a 5-year Profit Growth of 8.25% and an ROE of 12.62%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.

How does Sharda Cropchem Ltd compare with its industry peers?

Sharda Cropchem Ltd competes with major peers in the Pesticides & Agrochemicals. Investors should compare SHARDACROP's P/E of 17.41x and ROE of 12.62% against the industry averages to determine its competitive standing.

What is the P/E ratio of SHARDACROP and what does it mean?

SHARDACROP has a P/E ratio of 17.41x compared to the industry average of 29.36x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹17 for every ₹1 of annual earnings.

How is SHARDACROP performing according to Bull Run's analysis?

SHARDACROP has a Bull Run fundamental score of 68.3/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does SHARDACROP belong to?

SHARDACROP operates in the Pesticides & Agrochemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sharda Cropchem Ltd.

What is Return on Equity (ROE) and why is it important for SHARDACROP?

SHARDACROP has an ROE of 12.62%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Sharda Cropchem Ltd generates profits from shareholders' equity.

How is SHARDACROP's debt-to-equity ratio and what does it indicate?

SHARDACROP has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is SHARDACROP's dividend yield and is it a good dividend stock?

SHARDACROP offers a dividend yield of 1.03%, which means you receive ₹1.03 annual dividend for every ₹100 invested.

How has SHARDACROP grown over the past 5 years?

SHARDACROP has achieved 5-year growth rates of: Sales Growth 16.62%, Profit Growth 8.25%, and EPS Growth 8.25%.

What is the promoter holding in SHARDACROP and why does it matter?

Promoters hold 74.82% of SHARDACROP shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is SHARDACROP's market capitalization category?

SHARDACROP has a market capitalization of ₹7868 crores, placing it in the Mid-cap category.

How volatile is SHARDACROP stock?

SHARDACROP has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for SHARDACROP?

SHARDACROP has a 52-week high of ₹N/A and low of ₹N/A.

What is SHARDACROP's operating profit margin trend?

SHARDACROP has a 5-year average Operating Profit Margin (OPM) of 15.56%, indicating the company's operational efficiency.

How is SHARDACROP's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 19.59% and YoY Profit Growth of 75.22%.

What is the institutional holding pattern in SHARDACROP?

SHARDACROP has FII holding of 5.26% and DII holding of 9.26%. Significant institutional holding often suggests professional confidence in the stock.